Search alternatives:
significant causes » significant cause (Expand Search), significant causal (Expand Search), significant clusters (Expand Search)
causes increased » cases increased (Expand Search), use increased (Expand Search), values increased (Expand Search)
point decrease » point increase (Expand Search)
Showing 61 - 80 results of 36,192 for search '(( significant ((amount decrease) OR (point decrease)) ) OR ( significant causes increased ))', query time: 0.52s Refine Results
  1. 61
    Force capability according to the condition levels of the thigh brace.

    Force capability according to the condition levels of the thigh brace. by Jihun Kim (10091)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  2. 62
    Average stiffness for the force range of 100–150 N.

    Average stiffness for the force range of 100–150 N. by Jihun Kim (10091)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  3. 63
    Treatment with ICs causes a significant decrease in podocyte proliferation.

    Treatment with ICs causes a significant decrease in podocyte proliferation. by George Haddad (470789)

    Published 2023
    Save to List
    Saved in:
  4. 64
    Overall and sex-stratified paroxysmal tachycardia-related age-adjusted mortality rates per 100,000 in adults in the United States, 1999 to 2020.

    Overall and sex-stratified paroxysmal tachycardia-related age-adjusted mortality rates per 100,000 in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  5. 65
    S1 Graphical abstract -

    S1 Graphical abstract - by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  6. 66
    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by census regions in adults in the United States, 1999 to 2020.

    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by census regions in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  7. 67
    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000 in adults in the metropolitan and non-metropolitan areas in the United States, 1999 to 2020.

    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000 in adults in the metropolitan and non-metropolitan areas in the United States, 1999 to 2020. by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  8. 68
    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by race in adults in the United States, 1999 to 2020.

    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by race in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  9. 69
    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by age groups in adults in the United States, 1999 to 2020.

    Paroxysmal tachycardia-related age-adjusted mortality rates per 100,000, stratified by age groups in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 70
    Paroxysmal tachycardia-related deaths and age-adjusted mortality rates per 100,000, stratified by state in adults in the United States, 1999 to 2020.

    Paroxysmal tachycardia-related deaths and age-adjusted mortality rates per 100,000, stratified by state in adults in the United States, 1999 to 2020. by Aman Goyal (19231397)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  11. 71
    The experiment design and fertilization amount.

    The experiment design and fertilization amount. by Yu Liu (6938)

    Published 2024
    Save to List
    Saved in:
  12. 72
    Proportion of individuals’ general benefits scores that increased, decreased, or remained unchanged between time points.

    Proportion of individuals’ general benefits scores that increased, decreased, or remained unchanged between time points. by Jessie B. Moore (12578140)

    Published 2023
    Save to List
    Saved in:
  13. 73
    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Save to List
    Saved in:
  14. 74
    Table_1_Significantly Increased Risk of All-Cause Mortality Among Type 2 Diabetes Patients Living Alone.DOCX

    Table_1_Significantly Increased Risk of All-Cause Mortality Among Type 2 Diabetes Patients Living Alone.DOCX by Liyao Fu (11429449)

    Published 2022
    Save to List
    Saved in:
  15. 75
    MPA does not cause significant apoptosis effect in CN and CO.

    MPA does not cause significant apoptosis effect in CN and CO. by Intan Sofia Omar (10451088)

    Published 2022
    Save to List
    Saved in:
  16. 76
    Homozygous deletion of <i>ERG251</i> leads to increased sensitivity to cell membrane and osmotic stress but decreased sensitivity to oxidative stress.

    Homozygous deletion of <i>ERG251</i> leads to increased sensitivity to cell membrane and osmotic stress but decreased sensitivity to oxidative stress. by Xin Zhou (54275)

    Published 2024
    Save to List
    Saved in:
  17. 77
    Amount of change in the vertical deviation and angle of extorsion.

    Amount of change in the vertical deviation and angle of extorsion. by Soo Jung Lee (8313594)

    Published 2024
    Save to List
    Saved in:
  18. 78
    Metabolites with significantly increased abundance in murine nasopharynx vs lungs.

    Metabolites with significantly increased abundance in murine nasopharynx vs lungs. by Angharad E. Green (9667606)

    Published 2023
    Save to List
    Saved in:
  19. 79
    Metabolites with significantly increased abundance in murine lungs vs nasopharynx.

    Metabolites with significantly increased abundance in murine lungs vs nasopharynx. by Angharad E. Green (9667606)

    Published 2023
    Save to List
    Saved in:
  20. 80
    SUMOylation inhibitor 2-D08 does not cause any significant cell death.

    SUMOylation inhibitor 2-D08 does not cause any significant cell death. by Vandana Anang (17067624)

    Published 2023
    Save to List
    Saved in:

Search Tools: